This page shows the latest TerSera Therapeutics news and features for those working in and with pharma, biotech and healthcare.
This work has seen it agree deals with TerSera Therapeutics ($320m for Zoladex), ProStakan ($70m for Moventig), Aspen ($770m for seven anaesthetics drugs) and, most recently, Recordati ($300m for two blood
TerSera Therapeutics acquires rights to oncology drug in US and Canada. ... AstraZeneca has sold the rights to its big-selling cancer drug Zoladex in Canada and the US to TerSera Therapeutics, as the UK firm moves to focus on its newer oncology
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
In February, it granted North American rights to Zoladex, a goserelin acetate implant for prostate and breast cancer and benign gynaecological disorders, to US company TerSera Therapeutics. ... Licence. 358. AstraZeneca/ TerSera Therapeutics. Zoladex,
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
The company works with a range of innovative biopharma companies including UCB, Novo Nordisk, Astellas, Akebia, TerSera Therapeutics, Zogenix, BioMarin, and argenx.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...